Publication
PD09-07 Durvalumab in Combination with Bacillus Calmette-Guérin for Bacillus Calmette-Guérin-Naïve, High-Risk Non-Muscle-Invasive Bladder Cancer: Primary Results from a US-Based, Phase IIIB, Open-Label, Single-Arm, Multicenter Study (PATAPSCO): Erratum.
Gautam Jayram, Neal D Shore, Mark Tyson, Christopher Pieczonka, Peter Treasure, Adam Gadzinski, Brian Mazzarella, Moana Hodari, Kara Glover, Sushant Hardikar, Noah M Hahn
The Journal of urologyOct 1, 2026PMID 42713894doi:10.1097/JU.0000000000005149 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Bladder Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.